The New IPO: Lower Costs, Less Chaos


When it came time for Kindred Biosciences Inc.'s $53 million IPO, CEO Richard Chin decided to use a fast-growing software firm's time-saving product and estimated saving a half a million dollars.

For the latest information and news, visit The Workiva Press Page.

Upstart Business Journal